New Cervical Cancer Screening Test Introduced In El Salvador

“A new way to screen poor women for cervical cancer was introduced this month in El Salvador, using a test that was originally developed in China,” the New York Times reports. “The new test, called careHPV and made by Qiagen, a Dutch company, is a swab test for the DNA of the papillomaviruses that cause cancer,” the newspaper writes, noting a study published in the Lancet Oncology in 2008 found the test “was more than twice as sensitive” than the alternate method of “shining a light on the cervix and painting it with vinegar, which reveals precancerous lesions that can then be burned off with liquid nitrogen or carbon dioxide.” According to the New York Times, “The test worked even when women inserted the swabs themselves, which can be done at home and so is easier and faster than having them go to a clinic for visual inspections” (McNeil, 9/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.